Researchers have discovered a potential link between a specific blood type and an increased risk of breast cancer. Their ...

A study published in the Journal of Cancer Survivorship found that cancer survivors receiving high-cost immunotherapy ...

As of now, commissions on renewals will continue to be paid. Also, Leapfrog has served a cease-and-desist after Tenet Healthcare Corp. filed a lawsuit alleging that the safety grades process was ...

The Inflation Reduction Act, passed by Congress and signed into law by President Joe Biden in 2022, legislated new policies ...

As we age, our skin becomes more susceptible to damage, making seniors particularly vulnerable to skin cancer. Fortunately, advancements in medical treatments, such as photodynamic therapy, offer ...

Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population ...

Researchers projected CT use in 2023 would lead to more than 100,000 future cancer diagnoses, and if trends continued, may ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Remote symptom monitoring in cancer care reduces hospitalizations, enhances value-based care, and supports diverse patient ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Trump sets a 30-day deadline for drugmakers to lower the cost of prescription drugs in a sweeping executive order ...